Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $80.89M in the twelve months ending February 29, 2024, with 94.02% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $16.59M with 30.74% year-over-year growth. In the fiscal year ending November 30, 2023, Nurix Therapeutics had annual revenue of $76.99M with 99.31% growth.

• Revenue (ttm): $80.89M
• Revenue Growth: +94.02%
• P/S Ratio: 15.06
• Revenue / Employee: $284,813
• Employees: 284
• Market Cap: 1.22B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%
Nov 30, 2019	31.12M	-	-
Nov 30, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.